| Market Cap | ₹171Cr |
| ROE | 2.51% |
| P/E Ratio(TTM) | 0.00 |
| EPS(TTM) | 0.23 |
| P/B Ratio | 19.21 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.92 |
| Book Value | 7.84 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
| Parent Organisation | Mahavir Advanced Remedies Limited |
| Managing Director | Mr. BVS Rao |
| Founded | 1992 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 58.80 | ||
| Ajanta Pharma | NA (0.00%) | 32.25 | ||
| Gland Pharma | NA (0.00%) | 37.87 | ||
| Eris Lifesciences | NA (0.00%) | 50.71 |